{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:39:27Z","timestamp":1766158767318,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG2D0363","CMRPG2D0383","CMRPG2D0393"],"award-info":[{"award-number":["CMRPG2D0363","CMRPG2D0383","CMRPG2D0393"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002836","name":"Chang Gung University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bone.2021.116239","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T08:31:34Z","timestamp":1634891494000},"page":"116239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Impact of bisphosphonates and comorbidities on initial hip fracture prognosis"],"prefix":"10.1016","volume":"154","author":[{"given":"Tsai-Sheng","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Shuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chiau","family":"Shyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2011","key":"10.1016\/j.bone.2021.116239_bb0005","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00198-011-1601-6","article-title":"Secular trends in the incidence of hip and other osteoporotic fractures","volume":"22","author":"Cooper","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116239_bb0010","first-page":"193","article-title":"Diagnosis and treatment of osteoporosis","volume":"79","author":"Sweet","year":"2009","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bone.2021.116239_bb0015","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2021.116239_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.297.4.387","article-title":"Risk of subsequent fracture after low-trauma fracture in men and women","volume":"297","author":"Center","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2021.116239_bb0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","article-title":"A meta-analysis of previous fracture and subsequent fracture risk","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116239_bb0030","first-page":"493","article-title":"Ten-year risk of second hip fracture.A NOREPOS study","volume":"52","author":"Omsland","year":"2013"},{"key":"10.1016\/j.bone.2021.116239_bb0035","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00198-011-1811-y","article-title":"Excess mortality after hip fracture among elderly women in Norway. The HUNT study","volume":"23","author":"Gr\u00f8nskag","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116239_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bone.2013.05.015","article-title":"Excess mortality after hip fracture among the elderly in Taiwan: a nationwide population-based cohort study","volume":"56","author":"Wang","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116239_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1302\/0301-620X.94B1.27983","article-title":"Characteristics and outcome in patients sustaining a second contralateral fracture of the hip","volume":"94","author":"Sawalha","year":"2012","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.bone.2021.116239_bb0050","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00198-015-3104-3","article-title":"Excess mortality associated with second hip fracture","volume":"26","author":"Sobolev","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116239_bb0055","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1001\/archinte.167.18.1971","article-title":"Second hip fracture in older men and women: the Framingham study","volume":"167","author":"Berry","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2021.116239_bb0060","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1210\/jc.2013-1877","article-title":"Comparative effectiveness of osteoporosis drugs in preventing secondary nonvertebral fractures in Taiwanese women","volume":"98","author":"Lin","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116239_bb0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bone.2021.116239_bb0070","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.injury.2014.11.031","article-title":"The effect of osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and mortality in patients with hip fractures: a prospective functional and clinical outcome study on 520 patients","volume":"46","author":"Makridis","year":"2015","journal-title":"Injury"},{"issue":"2008","key":"10.1016\/j.bone.2021.116239_bb0075","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1185\/03007990802381430","article-title":"Post-fracture management of patients with hip fracture: a perspective","volume":"24","author":"Bruyere","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bone.2021.116239_bb0080","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2106\/JBJS.N.01275","article-title":"Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture: analysis of a large population sample","volume":"97","author":"Bawa","year":"2015","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2021.116239_bb0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/jpm11050341","article-title":"Adherence to anti-osteoporotic treatment and clinical implications after hip fracture: a systematic review","volume":"11","author":"Dobre","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.bone.2021.116239_bb0090","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ans.14507","article-title":"Incidence, timing and impact of comorbidity on second hip fracture: a population-based study","volume":"88","author":"Harvey","year":"2018","journal-title":"ANZ.J. Surg."},{"key":"10.1016\/j.bone.2021.116239_bb0095","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/aje\/kwy251","article-title":"The role of comorbidity in mortality after hip fracture: a Nationwide Norwegian study of 38,126 women with hip fracture matched to a general-population comparison cohort","volume":"188","author":"Lunde","year":"2019","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bone.2021.116239_bb0100","first-page":"435","article-title":"Osteoporosis\u2014a current view of pharmacological prevention and treatment","volume":"7","author":"Das","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.bone.2021.116239_bb0105","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.4158\/EP161435.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology: clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142016","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.bone.2021.116239_bb0110","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00198-006-0125-y","article-title":"Short time-frame from first to second hip fracture in the Funen County Hip Fracture Study","volume":"17","author":"Nymark","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116239_bb0115","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1359\/jbmr.090207","article-title":"Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977\u20132001","volume":"24","author":"Ryg","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116239_bb0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.aott.2016.06.008","article-title":"Incidence of second hip fractures and associated mortality in Taiwan: a nationwide population-based study of 95,484 patients during 2006-2010","volume":"50","author":"Lee","year":"2016","journal-title":"Acta. Orthop. Traumatol. Turc."},{"key":"10.1016\/j.bone.2021.116239_bb0125","first-page":"499","article-title":"Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: a meta-analysis","volume":"32","author":"Peng","year":"2016","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.bone.2021.116239_bb0130","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00198-012-2250-0","article-title":"Incidence of second hip fracture and compliant use of bisphosphonate","volume":"24","author":"Lee","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116239_bb0135","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/jamainternmed.2019.2779","article-title":"Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis","volume":"179","author":"Cummings","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.bone.2021.116239_bb0140","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2021.116239_bb0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12891-015-0670-7","article-title":"Is raloxifene associated with lower risk of mortality in postmenopausal women with vertebral fractures after vertebroplasty?: a hospital-based analysis","volume":"16","author":"Su","year":"2015","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bone.2021.116239_bb0150","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","article-title":"Fracture prevention with zoledronate in older women with osteopenia","volume":"379","author":"Reid","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2021.116239_bb0155","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00198-012-1984-z","article-title":"Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan","volume":"24","author":"Soong","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116239_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality","volume":"333","author":"Simpson","year":"2006","journal-title":"BMJ"},{"issue":"2012","key":"10.1016\/j.bone.2021.116239_bb0170","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.bone.2012.02.633","article-title":"Prediction of survival, second fracture, and functional recovery following the first hip fracture surgery in elderly patients","volume":"50","author":"Kim","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116239_bb0175","first-page":"203","article-title":"Excess mortality in men compared with women following a hip fracture.National analysis of comedications, comorbidity and survival","volume":"39","author":"Kannegaard","year":"2010"},{"issue":"2016","key":"10.1016\/j.bone.2021.116239_bb0180","first-page":"83","article-title":"Study of visuospatial skill in patients with dementia","volume":"19","author":"Pal","year":"2016","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.bone.2021.116239_bb0190","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.19706","article-title":"Risk factors and trends associated with mortality among adults with hip fracture in Singapore","volume":"3","author":"Yong","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bone.2021.116239_bb0195","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00198-007-0403-3","article-title":"Increased mortality in patients with a hip fracture\u2014effect of pre-morbid conditions and post-fracture complications","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116239_bb0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11657-017-0359-7","article-title":"Mortality risk among older australians hospitalised with hip fracture: a population-based matched cohort study","volume":"12","author":"Lystad","year":"2017","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bone.2021.116239_bb0205","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00198-011-1559-4","article-title":"Algorithms can be used to identify fragility fracture cases in physician-claims databases","volume":"23","author":"Jean","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116239_bb0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MLR.0b013e3181808c05","article-title":"Identification and validation of vertebral compression fractures using administrative claims data","volume":"47","author":"Curtis","year":"2009","journal-title":"Med. Care"},{"key":"10.1016\/j.bone.2021.116239_bb0215","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jclinepi.2012.10.004","article-title":"The validity of administrative data to identify hip fractures is high\u2013a systematic review","volume":"66","author":"Hudson","year":"2013","journal-title":"J. Clin. Epidemiol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221004051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221004051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:47:45Z","timestamp":1762660065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221004051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":41,"alternative-id":["S8756328221004051"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116239","relation":{},"ISSN":["8756-3282"],"issn-type":[{"type":"print","value":"8756-3282"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of bisphosphonates and comorbidities on initial hip fracture prognosis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116239"}}